PET/MRI scan to assess heart risk in sarcoidosis
Part of Heart & circulation, Immune system & allergy clinical trials.
This study checks whether a special heart scan called PET/MRI can predict how sarcoidosis may affect your heart. It may help doctors better estimate heart risk and plan follow-up based on scan findings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have sarcoidosis, and your doctor suspects it may involve your heart
- You may have heart symptoms (like fainting, ongoing palpitations, or heart failure signs) and/or heart rhythm or conduction problems (like certain heart blocks or rhythm issues)
- You must be able to have PET/MRI safely, including staying still and holding your breath for about 10 seconds
- You must be able to follow a low-carbohydrate diet for 24 hours and then fast for 6 hours before the scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a special PET scan with 64Cu-DOTATATE can detect inflammation in the heart caused by sarcoidosis. It may help diagnose heart sarcoidosis more accurately in people with symptoms or known disease.
This study follows people with sarcoidosis that may or may not be affecting the heart. It uses special scans (PET and MRI) to look for heart involvement and track how the disease changes over time.
This trial studies a treatment approach for people with active cardiac sarcoidosis, confirmed by specific heart rhythm/heart function problems and a PET scan. It may help by targeting the active inflammation driving heart conduction problems, rhythm events, or weak heart pumping.
This study tests how doctors can best tell whether someone has cardiac sarcoidosis, a condition where inflammation affects the heart. It may help you get a more accurate diagnosis using expert guidelines and special heart tests, and it groups patients as proven, probable, or unlikely.
This study collects and analyzes tissue or blood samples to better understand heart sarcoidosis and related inflammatory heart conditions. It may help doctors confirm diagnoses and improve care, especially in people with rhythm problems or results on heart scans.
This study tests whether a tracing agent called tilmanocept can help doctors see inflammation in the heart caused by sarcoidosis. It may provide a new way to diagnose and monitor cardiac sarcoidosis without invasive procedures.
Hear when a new Cardiac Sarcoidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.